Oregon Files Lawsuit Against GNC (GNC) for Selling Nutritional Supplements with Ingredients Not Approved in U.S.
- Tech stocks push S&P 500 to record close, buoy Nasdaq
- U.S. Calls for Pause of J&J (JNJ) Vaccine After Clotting Cases, Including One Death
- Coinbase (COIN) direct listing IPO reference price set at $250
- Biggest SPAC Deal Ever: Grab To Go Public in a $40 Billion Merger With Altimeter (AGC), Backed by Fidelity and BlackRock
- Oil rises after robust China data but J&J vaccine pause weighs
Oregon Files Lawsuit Against GNC Holdings (NYSE: GNC) for Selling Nutritional Supplements with Ingredients Not Approved in U.S.
October 22, 2015
Attorney General Ellen Rosenblum today filed a lawsuit against General Nutrition Corporation, GNC, for selling nutritional and dietary supplements containing the illegal ingredients picamilon and BMPEA. The lawsuit alleges that the company violated the Oregon Unlawful Trade Practices Act (UTPA) by misrepresenting certain products as lawful dietary supplements when they are actually unapproved drugs that may not be lawfully sold in the United States as a dietary supplement. The complaint also alleges that GNC sold products labeled as containing botanical acacia rigidula that had been spiked with unlabeled BMPEA.
“It is scary to know that certain products sold by GNC contain an ingredient that is not even labeled—let alone approved in the United States,” said Attorney General Rosenblum. “When Oregonians buy a dietary supplement, they deserve to know that the ingredients in the products are safe and comply with the law. There are 25 GNC stores in Oregon that sold thousands of these products over the span of a couple of years.”
The lawsuit, which was filed in Multnomah Circuit Court, also alleges that GNC sold thousands of units of products in Oregon that contained picamilon or BMPEA that were falsely labeled as a dietary supplement.
Picamilon is a synthetic chemical that is not approved in the United States, but is used as a prescription drug in some countries to treat neurological conditions. Products containing BMPEA, a powerful stimulant and amphetamine-like substance, are sometimes sold as weight loss or performance enhancing nutritional supplements.
Attorney General Rosenblum once again commended the work of Assistant Attorney General David Hart and his DOJ team. In May, Mr. Hart led an Oregon settlement with the national retailer Vitamin Shoppe to ban BMPEA from its products. The Attorney General also commended the work of the Food and Drug Administration (FDA) for their technical assistance in the investigation.
The complaint can be found here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Credit Suisse (CS) selling 19 million shares of of Discovery (DISCA) and 22 million shares of DISCK (DISCK) - CNBC's Faber
- Joint CDC and FDA Statement on Johnson & Johnson (JNJ) COVID-19 Vaccine
- Stitch Fix (SFIX) Announces Founder and CEO Katrina Lake to become Executive Chairperson and Elizabeth Spaulding to become CEO August 1
Create E-mail Alert Related CategoriesCorporate News, Hot Corp. News, Litigation, Trader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!